All, n=2243 | GA, n=1816 | Non-GA, n=427 | P values | |
Valve type | ||||
Edwards Sapien | 1365 (60.9) | 1125 (61.9) | 240 (56.2) | 0.032 |
Medtronic CoreValve | 878 (39.1) | 691 (38.1) | 187 (43.8) | |
Delivery approach | ||||
Percutaneous | 1792 (79.9) | 1385 (76.3) | 407 (95.3) | < 0.001 |
Surgical cut down | 451 (20.1) | 431 (23.7) | 20 (4.7) | |
Procedural imaging | ||||
Transoesophageal echocardiography | 1729 (77.1) | 1676 (92.3) | 53 (12.4) | < 0.001 |
None or other | 514 (22.9) | 140 (7.7) | 374 (87.6) | |
Predeployment balloon valvuloplasty | 1365 (60.9) | 1139 (62.8) | 226 (52.9) | <0.001 |
Postdeployment balloon dilatation | 304 (13.8) | 251 (14.1) | 53 (12.8) | 0.528 |
Successful valve deployment | 2154 (96.9) | 1750 (97.2) | 404 (95.7) | 0.104 |
Aortic regurgitation at the end of the procedure, any degree | 1181 (53.9) | 966 (54.4) | 215 (51.7) | 0.326 |
Aortic regurgitation at the end of the procedure, more than mild | 128 (5.8) | 99 (5.6) | 29 (7.0) | 0.295 |
Conversion to full sternotomy | 31 (1.4) | 28 (1.5) | 3 (0.7) | 0.249 |
Acute kidney injury within 7 days of the procedure | 137 (6.2) | 107 (6.0) | 30 (7.4) | 0.307 |
New dialysis before discharge | 42 (1.9) | 36 (2.0) | 6 (1.5) | 0.554 |
Tamponade during or after procedure | 53 (2.4) | 43 (2.4) | 10 (2.4) | >0.999 |
Cerebrovascular attack up to discharge | 53 (2.38) | 42 (2.3) | 11 (2.6) | 0.722 |
Major or life-threatening bleeding | 103 (4.7) | 58 (4.4) | 18 (4.4) | 0.897 |
Vascular access site complications | 238 (10.7) | 198(11) | 40 (9.5) | 0.430 |
Procedure time (min) | 129.1±59.9 | 131±60.0 | 121±60.0 | 0.002 |
Length of stay in hospital (days) | 7.6±12.4 | 8.0±13.5 | 5.7±5.5 | <0.001 |
Values are mean±SD or n (%).
GA, general anaesthesia.